Fibroblast Growth Factor-23 as a Possible Cause of Left Ventricular Hypertrophy and Pulmonary Hypertension in Hemodialysis Patients - Tamer Taha

↳ This is a section part of Moment: CardioAlex 2016 - Rapid Fire Abstracts - Cardiovascular

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$3.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Fibroblast Growth Factor-23 as a Possible Cause of Left Ventricular Hypertrophy and Pulmonary Hypertension in Hemodialysis Patients presented by Tamer Taha

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$3.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Cardiologists
  • Rheumatologists
  • Pulmonologists

Learning Objectives

  • Educate HCPs on data in Pulmonary Hypertension and CV Risk of RA Patients

Other Components in this Moment

Overview
Correlation Between Tumor Necrosis Factoralpha and Cardiovascular Complication in Rheumatoid Arthritis Patients - Mohamed Sayed Bashandy
Fibroblast Growth Factor-23 as a Possible Cause of Left Ventricular Hypertrophy and Pulmonary Hypertension in Hemodialysis Patients - Tamer Taha
Loading Simple Education